Fulcrum Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.98M | Sell |
5,476
-4,482
| -45% | -$1.53M | 0.4% | 43 |
|
|
2026
Q1 | $3.5M | Sell |
9,958
-91
| -0.9% | -$32.4K | 0.76% | 35 |
|
|
2025
Q4 | $3.29M | Sell |
10,049
-98
| -1% | -$31.1K | 0.66% | 37 |
|
|
2025
Q3 | $2.86M | Buy |
10,147
+109
| +1% | +$31.6K | 0.59% | 37 |
|
|
2025
Q2 | $2.8M | Sell |
10,038
-97
| -1% | -$27.5K | 0.59% | 38 |
|
|
2025
Q1 | $3.16M | Buy |
10,135
+190
| +2% | +$56.1K | 0.7% | 37 |
|
|
2024
Q4 | $2.59M | Sell |
9,945
-44
| -0.4% | -$13.1K | 0.54% | 38 |
|
|
2024
Q3 | $3.22M | Sell |
9,989
-76
| -0.8% | -$24.9K | 0.7% | 37 |
|
|
2024
Q2 | $3.14M | Buy |
10,065
+399
| +4% | +$117K | 0.72% | 35 |
|
|
2024
Q1 | $2.75M | Buy |
9,666
+228
| +2% | +$66.7K | 0.65% | 37 |
|
|
2023
Q4 | $2.72M | Sell |
9,438
-3,043
| -24% | -$829K | 0.7% | 37 |
|
|
2023
Q3 | $3.35M | Sell |
12,481
-505
| -4% | -$126K | 0.97% | 32 |
|
|
2023
Q2 | $2.88M | Sell |
12,986
-381
| -3% | -$88.4K | 0.76% | 37 |
|
|
2023
Q1 | $3.23M | Buy |
13,367
+878
| +7% | +$216K | 0.87% | 36 |
|
|
2022
Q4 | $3.28M | Buy |
12,489
+1,251
| +11% | +$335K | 0.95% | 36 |
|
|
2022
Q3 | $2.53M | Sell |
11,238
-588
| -5% | -$143K | 0.75% | 42 |
|
|
2022
Q2 | $2.88M | Buy |
11,826
+10,776
| +1,026% | +$2.64M | 0.9% | 36 |
|
|
2022
Q1 | $254K | Hold |
1,050
| – | – | 0.07% | 64 |
|
|
2021
Q4 | $236K | Hold |
1,050
| – | – | 0.05% | 79 |
|
|
2021
Q3 | $223K | Sell |
1,050
-287
| -21% | -$66.1K | 0.05% | 83 |
|
|
2021
Q2 | $326K | Sell |
1,337
-120
| -8% | -$29.5K | 0.08% | 64 |
|
|
2021
Q1 | $363K | Sell |
1,457
-608
| -29% | -$145K | 0.1% | 63 |
|
|
2020
Q4 | $475K | Buy |
2,065
+946
| +85% | +$218K | 0.14% | 54 |
|
|
2020
Q3 | $284K | Hold |
1,119
| – | – | 0.1% | 53 |
|
|
2020
Q2 | $264K | Buy |
+1,119
| New | +$255K | 0.1% | 59 |
|
|
2020
Q1 | – | Sell |
-985
| Closed | -$237K | – | 65 |
|
|
2019
Q4 | $237K | Sell |
985
-165
| -14% | -$36.4K | 0.07% | 68 |
|
|
2019
Q3 | $223K | Hold |
1,150
| – | – | 0.08% | 67 |
|
|
2019
Q2 | $212K | Sell |
1,150
-115
| -9% | -$20.6K | 0.08% | 56 |
|
|
2019
Q1 | $240K | Buy |
1,265
+200
| +19% | +$38.2K | 0.09% | 55 |
|
|
2018
Q4 | $207K | Hold |
1,065
| – | – | 0.09% | 54 |
|
|
2018
Q3 | $221K | Buy |
+1,065
| New | +$210K | 0.09% | 59 |
|
|
2018
Q1 | – | Sell |
-1,489
| Closed | -$259K | – | 69 |
|
|
2017
Q4 | $259K | Buy |
+1,489
| New | +$264K | 0.08% | 67 |
|
Other funds holding AMGN
FFM
SP
Fulcrum Capital's AMGN Position: Q2 2026 in Review
Fulcrum Capital reduced its Amgen (AMGN) stake by 45% in Q2 2026, selling an estimated $1.53M and leaving 5,476 shares worth $1.98M. The position accounts for 0.4% of the portfolio, ranked #43.
Fulcrum Capital first reported a position in AMGN in Q4 2017 and has held it in 32 quarters since. The position peaked at $3.5M in Q1 2026. 1,334 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Fulcrum Capital held 5,476 shares of Amgen worth $1.98M as of Q2 2026.
- Fulcrum Capital sold 4,482 Amgen shares in Q2 2026, an estimated $1.53M.
- Amgen made up 0.4% of Fulcrum Capital's portfolio in Q2 2026, its #43 holding.
- Fulcrum Capital first reported a position in Amgen in Q4 2017 and has held it in 32 quarters since.
- Fulcrum Capital's Amgen position peaked at $3.5M in Q1 2026.
- 1,334 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Fulcrum Capital's 13F filing for Q2 2026, filed 21 Jul 2026.